Table 1.
The numbers of squares with urine pool and fecal boli for C57 males toward a CD-1 (a; Exp. 1) and toward a C57 (d; Exp. 3), and CD-1 males toward a C57 (b) and toward a CD-1 (c) (Exp. 2) for each trial. Test trials are shown in T5 at panel (a) in which each C57 was exposed to a novel CD-1, T5 and T6 at panel (b) in which each CD-1 was confronted with a novel C57 and a CD-1, respectively, T4 at panel (c) in which each CD-1 was confronted with a novel CD-1, and T5 and T6 at panel (d) in which each C57 was confronted with a novel C57 and CD-1, respectively.
| a | C57 vs. CD-1 |
b | CD-1 vs. C57 |
c | CD-1 vs. CD-1 |
d | C57 vs. C57 |
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pool size | Fecal boli | Pool size | Fecal boli | Pool size | Fecal boli | Pool size | Fecal boli | ||||
| T1 | 19.1(4.1) | 4.1(0.6) | T1 | 14.1(4.4) | 5.5(0.7) | T1 | 6.3(3.2) | 8.7(0.8) | T1 | 16.8(3.6) | 5.0(0.7) |
| T2 | 15.8(5.2) | 4.4(0.8) | T2 | 6.6(3.1) | 7.2(0.8) | T2 | 7.8(3.1) | 8.3(0.8) | T2 | 17.1(4.0) | 4.8(0.7) |
| T3 | 9.6(3.4) | 3.5(0.5) | T3 | 6.1(2.9) | 7.6(0.8) | T3 | 5.1(2.0) | 7.9(0.7) | T3 | 13.8(4.4) | 4.2(0.5) |
| T4 | 7.1(3.2) | 2.5(0.4) | T4 | 5.6(4.7) | 7.5(0.7) | T4 | 13.3(3.9) | 4.3(0.6) | |||
| T4 | 1.9(1.4) | 8.1(0.7) | |||||||||
| T5 | 14.9(4.0) | 3.3(0.7) | T5 | 11.6(5.7) | 8.2(0.7) | T5 | 14.6(4.8) | 4.0(0.7) | |||
| T6 | 1.6(1.2) | 8.1(0.5) | T6 | 7.2(4.3) | 4.0(0.5) | ||||||
Data are means (S.E.M.). There were no significant trial differences